Genomics Shares Higher Following Celera Announcement | GenomeWeb

NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning.

Shares of Celera jumped 3.3, or 7.9 percent, to 44.90 in morning trading, while shares of sister company Applied Biosystems were also up, rising 3.49, or 4.8 percent, to 76.40.

Celera’s main competitor in the data war, Incyte, was also up, albeit a more moderate 5/16, or 1.5 percent, at 20 13/16.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.